Minnetronix Medical Launches World’s First Expandable Brain Port, Now Available to Neurosurgical Market

With successful human use and new distribution partnership, Minnetronix’s first internally conceived and commercialized product takes med device partnerships to the next level

SAINT PAUL, Minn. (August 11, 2022) – Minnetronix Medical’s first product — conceptualized, developed, FDA-cleared, and manufactured internally — is now fully commercialized and available to the neurosurgery market. The only expandable brain access port on the market, the MindsEye™ expandable port is the result of Minnetronix using its 25 years of experience as a med device partner to identify unmet needs in the neuro market and create its own market-ready products for sale and distribution. Mizuho America has signed on to distribute the MindsEye expandable port in the U.S.

“Minnetronix is taking partnerships in the med device industry to a whole new level, which sets us apart from contract developers and manufacturers,” said Matt Adams, vice president and general manager at Minnetronix Medical. “Our first from-scratch product showcases our end-to-end capabilities to support our customers’ needs across device conceptualization and design, clinical research and partnerships, regulatory navigation, and manufacturing. We offer a whole new way for med device companies, startups, and investors to reduce the cost, risk, and time of building products themselves.”

The MindsEye expandable port, the first minimally invasive, expandable port providing deep brain access and visualization during surgical treatment of stroke, cancer, and other conditions, is being used successfully at Tulane University by Dr. Art Wang and Dr. Johnny Delashaw. “Its benefits to neurosurgeons, such as expandability, easier insertion and removal, and transparency that minimizes glare and allows surgeons to see surrounding tissue, are truly unique,” said Dr. Delashaw, Tulane neurosurgeon and neurology professor. “The MindsEye expandable port has raised the bar for standard of care in neurosurgery and will improve patient outcomes.”

The MindsEye expandable port garnered four major industry awards for its unique technology and design, even before it was available to the market.

“Mizuho’s mission is to deliver the best devices to neurosurgeons,” said William Delaney, vice president of sales at Mizuho America, a company with 30 years of history in developing the most advanced medical devices for neurosurgeons across the globe. “We now consider Minnetronix a partner for new device ideas and finished products. Since they handled all the steps in creating the MindsEye expandable port, we can concentrate on bringing it to market by leveraging the strength of our distribution channel to accelerate adoption and enhance patient outcomes.”

About Minnetronix Medical

Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development, and manufacturing partner to leading device companies around the world. Today, through lifecycle efficiency, opportunity realization, and increased utility, the company creates value in key technology segments that include RF energy, fluid and gas management, optical systems, and stimulation and active wearables. From design and manufacturing services to whole product solutions, Minnetronix has the expansive industry insight and intentional technical acumen to deliver better medical devices to market, faster.